美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Novo Nordisk A/S B Shares ADRhedged

22.35

+0.08260.37%

盤後：22.34-0.0145-0.06%16:10 EDT

成交量：3,176.00

成交額：6.91萬

市值：424.74萬

市盈率：- -

高：22.39

開：20.04

低：20.01

收：22.27

52周最高：43.73

52周最低：19.00

股本：19.00萬

流通股本：19.00萬

量比：1.13

換手率：1.67%

股息：0.93

股息率：4.15%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

司美格魯肽口服減重藥已開出超60萬張處方，市場空間還有多大

諾和諾德CEO：全球減重市場潛力巨大

环球市场播报

口服減重藥大戰已打響！禮來、諾和諾德首年爭奪約50億美元市場

諾和諾德稱：口服版Wegovy減肥效果優於禮來GLP‑1口服藥

环球市场播报

減肥藥雙雄對決升級！禮來殺入「口服版」戰場

禮來口服減肥藥獲批加劇與諾和諾德競爭

諾和諾德每周一次基礎胰島素製劑Awiqli獲美國FDA批准

諾和諾德「周製劑」胰島素獲美國FDA批准上市

美股異動丨諾和諾德盤前升逾2%，「周製劑」胰島素在美獲批上市

糖果巨頭CEO加盟減重藥巨頭諾和諾德

諾和諾德任命瑪氏公司CEO為董事會觀察員

減重巨頭決戰線上，「可及性」成關鍵賽點

「減肥神藥」，價格要崩了

減重版司美格魯肽「上新」，更高劑量Wegovy已在美國獲批

21世纪经济报道

凌激副部長兼國際貿易談判副代表會見丹麥諾和諾德公司執行副總裁林意明

南方财经网

諾和諾德(NVO.US)擬在日本拓展減肥藥市場，「曲線入市「瞄準自費患者藍海

諾和諾德據悉正尋求拓寬日本患者獲取減肥藥的渠道

諾和諾德(NVO)股票3月18日盤中下跌3.12%：投資者必看的核心信息

TradingKey中文

Structure肥胖藥物研究結果直追諾和諾德與禮來

反彈50%只是開始？深度覆盤HIMS與藥王的「世紀大和解」

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NVOH/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":22.3545,"timestamp":1776369600000,"preClose":22.2719,"halted":0,"volume":3176,"hourTrading":{"tag":"盘后","latestPrice":22.34,"preClose":22.3545,"latestTime":"16:10 EDT","volume":6,"amount":134.127,"timestamp":1776370204125,"change":-0.0145,"changeRate":-0.000649,"amplitude":0},"delay":0,"changeRate":0.003708709180626839,"floatShares":190001,"shares":190001,"eps":0,"marketStatus":"未開盤","change":0.0826,"latestTime":"04-16 16:00:00 EDT","open":20.04,"high":22.39,"low":20.01,"amount":69084.2,"amplitude":0.106861,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":22.2719,"nav":22.290632,"aum":4235242.370632,"dividendRate":0.041535,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":22.34,"preClose":22.3545,"latestTime":"16:10 EDT","volume":6,"amount":134.127,"timestamp":1776370204125,"change":-0.0145,"changeRate":-0.000649,"amplitude":0},"volumeRatio":1.129124,"impliedVol":0.2556,"impliedVolPercentile":0.1818},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":190001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.129124,"shares":190001,"dividePrice":0.9285,"high":22.39,"amplitude":0.106861,"preClose":22.2719,"low":20.01,"week52Low":19,"pbRate":"--","week52High":43.73,"institutionHeld":0,"latestPrice":22.3545,"eps":0,"divideRate":0.041535,"volume":3176,"delay":0,"ttmEps":0,"open":20.04,"prevYearClose":27.4362,"prevWeekClose":20.6636,"prevMonthClose":20.5842,"prevQuarterClose":20.5842,"fiveDayClose":20.6683,"twentyDayClose":20.6,"sixtyDayClose":32.7865},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2625962091","title":"司美格魯肽口服減重藥已開出超60萬張處方，市場空間還有多大","url":"https://stock-news.laohu8.com/highlight/detail?id=2625962091","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625962091?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 15:05","pubTimestamp":1775459100,"startTime":"0","endTime":"0","summary":"由于投资人担心诺和诺德的司美格鲁肽减重药市场份额进一步下滑，今年至今，诺和诺德股价累计跌幅接近30%，目前市值不到1300亿美元。晨星公司估计，到2034年，口服减重药可能占据1800亿美元的全球减重药市场规模的约三分之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-06/doc-inhtpvua4544996.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-06/doc-inhtpvua4544996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4534","BK4588","BK4007","BK4599","IE00BKVL7J92.USD","BK4532","LU0154236417.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","NVOX","BK4118","LU1863844665.USD","LU1829250122.USD","LLY","NVO","LU3187612489.SGD","LU1863844749.USD","LU1093756325.SGD","BK4585","NVOH","IE0034235071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625664396","title":"諾和諾德CEO：全球減重市場潛力巨大","url":"https://stock-news.laohu8.com/highlight/detail?id=2625664396","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625664396?lang=zh_tw&edition=fundamental","pubTime":"2026-04-05 13:08","pubTimestamp":1775365680,"startTime":"0","endTime":"0","summary":"诺和诺德公司首席执行官迈克杜斯塔达尔在接受采访时表示，制药企业对全球减重市场的开发还仅仅是“浅尝辄止”，企业应着力扩大药物的可及性。　　扩大药物可及性的需求，也是诺和诺德同意为美国总统特朗普的处方药网站TrumpRx下调药品售价的原因之一。　　诺和诺德还计划从明年1月起，将Wegovy在美国的批发价下调50%，Ozempic下调35%。　　诺和诺德希望，今年推出口服版Wegovy能够帮助其在被竞争对手礼来公司夺走市场领先地位后收复失地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-05/doc-inhtmnnx5274969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","BK4588","BK4585","LU1093756168.USD","NVOX","LU1093756325.SGD","BK4532","LU0154236417.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVOH","BK4599","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624765809","title":"口服減重藥大戰已打響！禮來、諾和諾德首年爭奪約50億美元市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2624765809","media":"第一财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624765809?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 15:14","pubTimestamp":1775200446,"startTime":"0","endTime":"0","summary":"在礼来公司的口服减重药Orforglipron（商品名：Foundayo）获得美国FDA批准上市的第二天，第一财经记者了解到，目前礼来已开展7项Orforglipron针对肥胖及2型糖尿病的三期临床研究，全球累计入组患者逾万人，其中中国患者参与了6项全球多中心研究。此次美国FDA批准该药物上市所基于的ATTAIN系列临床研究也纳入了中国患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604033694898132.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033694898132.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0882574055.USD","GB00BDT5M118.USD","IE00BKPKM429.USD","LU2168564222.USD","IE0004445239.USD","LU1868836757.USD","LU2471134523.USD","LU1720051108.HKD","LU2552382215.SGD","LU1023059063.AUD","IE00BKVL7J92.USD","LU2361044949.HKD","LU2471134796.USD","IE00B2B36J28.USD","LU2462157665.USD","LU2471134952.CNY","LU1629891620.HKD","LU1974910355.USD","SG9999014898.SGD","LU0320765992.SGD","LU2552382058.USD","LU0417517546.SGD","LU1868836591.USD","LU2237443549.SGD","SG9999014880.SGD","LU1057294990.SGD","IE00BJLML261.HKD","LU1989771016.USD","SG9999015952.SGD","LU2271345857.HKD","LU2168564065.EUR","LU2112291526.USD","SG9999014906.USD","IE00B1XK9C88.USD","LU0225283273.USD","LU1548497426.USD","SGXZ51526630.SGD","LU1983299246.USD","LU2236285917.USD","LU0708995401.HKD","IE00BK4W5M84.HKD","LU2746668974.SGD","LU0786609619.USD","LU2491050071.SGD","LU1267930730.SGD","LU2089984988.USD","SG9999001176.SGD","LU0058720904.USD","LU0889565916.HKD","SG9999014914.USD","LU0471298777.SGD","LU0109394709.USD","LU1064131342.USD","LU1291159041.SGD","LU0158827948.USD","LU0823434583.USD","LU2750360641.GBP","LU2750360997.AUD","LU0432979614.USD","LU0316494557.USD","LU0266013472.USD","LU0640476718.USD","ELIL","LU0823416689.USD","IE00BJJMRY28.SGD","LLY","LU0823434740.USD","LU1035775433.USD","IE00BN29S564.USD","LU2237438978.USD","LU1551013342.USD","LU0238689110.USD","LU0106261372.USD","LU2106854487.HKD","BK4599","SG9999015945.SGD","SG9999013999.USD","BK4007","LU2087625088.SGD","BK4516","LU1145028129.USD","LU2237443622.USD","LU2361045086.USD","IE00B775H168.HKD","LU2028103732.USD","LU0289739699.SGD","LU2468319806.SGD","LU1280957306.USD","LU2357305700.SGD","BK4581","LU1093756325.SGD","BK4533","SGXZ81514606.USD","IE00B7KXQ091.USD","IE00BJT1NW94.SGD","LU2023250504.SGD","LU2552382132.HKD","SG9999018857.SGD","BK4534","LU2023251221.USD","LU0203202063.USD","LU0210536198.USD","LU2756315664.SGD","LU2023250330.USD","LU1868836914.USD","LU2063271972.USD","LU0820562030.AUD","IE00BWXC8680.SGD","LU1623119135.USD","LU2108987350.USD","IE00BKDWB100.SGD","LU2237443895.HKD","LU2602419157.SGD","LU0203201768.USD","LU0672654240.SGD","LU2456880835.USD","LU1127390331.HKD","LU0882574139.USD","NVOH","LU2264538146.SGD","SG9999018865.SGD","LU2237443382.USD","LU2491050154.USD","SG9999015978.USD","LU2756315318.SGD","IE00B4JS1V06.HKD","LU0114720955.EUR","LU1868837136.USD","SG9999017495.SGD","LLYZ","LU1868837300.USD","LU1069344957.HKD","LU1093756168.USD","SG9999001176.USD","LU0256863811.USD","LU2211815571.USD","IE00BJJMRZ35.SGD","LU0787776722.HKD","LU0323591593.USD","LU2491049909.HKD","LU2237443465.HKD","LU0820561909.HKD","NVO","LU0158827781.USD","IE0002141913.USD","LU0466842654.USD","LU2461242641.AUD","LU2324357040.USD","LLYX","LU0256863902.USD","LU0354030511.USD","LU0320765059.SGD","BK4532","LU0198837287.USD","SGXZ57979304.SGD","LU0154236417.USD","LU0079474960.USD","LU2168564495.EUR","LU1366192091.USD","IE00BFTCPJ56.SGD","LU0385154629.USD","LLII","LU2896262040.SGD","LU1804176565.USD","LU2237443978.SGD","LU2746668461.USD","IE00B1BXHZ80.USD","SGXZ99366536.SGD","LU0094547139.USD","NVOX","LU1551013425.SGD","IE00BZ1G4Q59.USD","LU0353189763.USD","LU0006306889.USD","SGXZ31699556.SGD","LU0456855351.SGD","IE0004445015.USD","LU2089283258.USD","LU2111349929.HKD","SG9999015986.USD","LU0353189680.USD","LU1814569148.SGD","LU0109391861.USD","LU1232071149.USD","LU0689472784.USD","IE00B4R5TH58.HKD","LU2168564149.EUR","LU1917777945.USD","LU2471134879.HKD","IE00BJJMRX11.SGD","LU0471298694.HKD","IE0001KFT4U8.USD","LU1988902786.USD","IE0005OL40V9.USD","LU2089284900.SGD","LU1712237335.SGD","LU2265009873.SGD","IE00BK4W5L77.USD","LU2360106947.USD","IE00BFSS7M15.SGD","IE0009355771.USD","LU2213496289.HKD","IE00BFSS8Q28.SGD","LU2168563687.JPY","LU1720051017.SGD","LU1061106388.HKD","LU2417539215.USD","LU0096364046.USD","LU0683600562.USD","LU0354030438.USD","BK4585","LU0122379950.USD","ELIS","LU1323610961.USD","LU2361044865.SGD","LU0820561818.USD","LU0097036916.USD","LU0061475181.USD","LU0234572021.USD","LU0943347566.SGD","LU0964807845.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624501755","title":"諾和諾德稱：口服版Wegovy減肥效果優於禮來GLP‑1口服藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2624501755","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624501755?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 21:02","pubTimestamp":1775134920,"startTime":"0","endTime":"0","summary":"诺和诺德周四表示，口服版 Wegovy 的平均减重效果显著优于礼来本周刚获批的竞品药物 Foundayo。诺和诺德称，另一项分析显示，84% 的患者更偏好与 Wegovy 相似的药物特性，而非 Foundayo。　　此前研究显示，口服 Wegovy 平均减重幅度达16.6%；而坚持完成疗程的患者服用 Foundayo 后，平均减重约12.4%。　　自 1 月初口服 Wegovy 在美国上市以来，处方量飙升，已有超 60 万名患者开始服用。　　诺和诺德周四称，最新研究结果表明，口服 Wegovy 具备差异化竞争力。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-02/doc-inhtcnfs0874567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","IE00BFSS8Q28.SGD","LU1232071149.USD","IE00BJJMRY28.SGD","LU0154236417.USD","LU2361045086.USD","LU1551013425.SGD","LU2361044865.SGD","LU0006306889.USD","LU0061475181.USD","LU0109391861.USD","LU1548497426.USD","LU1868837136.USD","LU2471134796.USD","SG9999001176.SGD","SG9999017495.SGD","LU1551013342.USD","LU2236285917.USD","LU0354030511.USD","LU0672654240.SGD","LU0256863902.USD","LU2089283258.USD","LU2265009873.SGD","LU2552382058.USD","LU2106854487.HKD","LU0158827948.USD","LU1127390331.HKD","LLY","LU0203201768.USD","IE00BKDWB100.SGD","IE00B4R5TH58.HKD","LU0234572021.USD","IE00BZ1G4Q59.USD","LU0238689110.USD","IE00BFSS7M15.SGD","LU1069344957.HKD","BK4588","LU2750360997.AUD","SG9999014914.USD","SG9999001176.USD","LU0114720955.EUR","LU2491050071.SGD","LU0708995401.HKD","LU1366192091.USD","LU2264538146.SGD","LU2357305700.SGD","IE00BK4W5M84.HKD","LU1988902786.USD","LU2471134952.CNY","LU2417539215.USD","LU0058720904.USD","BK4007","IE0009355771.USD","LU1093756325.SGD","LU2063271972.USD","SG9999018857.SGD","LU2111349929.HKD","LU0786609619.USD","LU0198837287.USD","SG9999014880.SGD","LU0889565916.HKD","LU0823434583.USD","LU0456855351.SGD","LU0787776722.HKD","LU2211815571.USD","LU0820562030.AUD","SGXZ81514606.USD","LU1035775433.USD","LU2324357040.USD","LU2746668461.USD","IE00BFTCPJ56.SGD","LU0964807845.USD","IE00B7KXQ091.USD","LU1057294990.SGD","LU2462157665.USD","LU2089984988.USD","LU0320765059.SGD","LLYX","LU0471298694.HKD","LU2237443622.USD","LU0320765992.SGD","LLYZ","LU0323591593.USD","IE00BJT1NW94.SGD","LU1814569148.SGD","SG9999015978.USD","BK4144","LU1629891620.HKD","LU2023251221.USD","LU0097036916.USD","LU2602419157.SGD","SG9999015986.USD","IE0002141913.USD","SGXZ31699556.SGD","LU2552382132.HKD","LU0385154629.USD","LU1712237335.SGD","LU0266013472.USD","LU0466842654.USD","LU2456880835.USD","BK4534","LU0106261372.USD","LU1061106388.HKD","LU0316494557.USD","LU1291159041.SGD","BK4533","LU0943347566.SGD","LU0823434740.USD","IE00BJLML261.HKD","LU1989771016.USD","LU2168564495.EUR","LU0417517546.SGD","LU0823416689.USD","LU0354030438.USD","LU2237443465.HKD","LU2108987350.USD","BK4581","LU1267930730.SGD","IE00B2B36J28.USD","LU1868836591.USD","BK4532","IE00B1BXHZ80.USD","LU1064131342.USD","LU0640476718.USD","LU2028103732.USD","LU0471298777.SGD","LU0210536198.USD","LU2089284900.SGD","ELIL","BK4516","LU1720051108.HKD","IE0004445015.USD","LU1145028129.USD","LU1093756168.USD","SG9999014906.USD","LU2491049909.HKD","LU2237443382.USD","LU2237443549.SGD","BK4590","LU1804176565.USD","SG9999013999.USD","LU0820561818.USD","SG9999014898.SGD","IE00BJJMRX11.SGD","BK4599","LU0158827781.USD","IE00B1XK9C88.USD","LU2168564222.USD","LU2896262040.SGD","LLII","LU2237443978.SGD","LU2756315664.SGD","NVO","LU0882574055.USD","IE00BJJMRZ35.SGD","IE00B775H168.HKD","LU1023059063.AUD","SG9999018865.SGD","LU0353189680.USD","LU2168563687.JPY","IE00BKVL7J92.USD","IE00BN29S564.USD","LU0289739699.SGD","LU0256863811.USD","LU0353189763.USD","IE0001KFT4U8.USD","LU2023250330.USD","LU1280957306.USD","LU1623119135.USD","IE00BKPKM429.USD","LU2168564149.EUR","IE0005OL40V9.USD","SGXZ51526630.SGD","LU2750360641.GBP","NVOX","SG9999015945.SGD","LU2471134879.HKD","LU0432979614.USD","LU0094547139.USD","LU2023250504.SGD","LU2168564065.EUR","GB00BDT5M118.USD","LU0689472784.USD","LU1868836757.USD","LU0109394709.USD","LU2552382215.SGD","SGXZ57979304.SGD","LU2491050154.USD","LU2468319806.SGD","LU2360106947.USD","ELIS","IE00B4JS1V06.HKD","LU0683600562.USD","SG9999015952.SGD","LU1868837300.USD","LU0882574139.USD","LU0096364046.USD","LU1868836914.USD","LU2361044949.HKD","LU0079474960.USD","IE0004445239.USD","LU1917777945.USD","LU2087625088.SGD","LU2237438978.USD","LU2461242641.AUD","LU1974910355.USD","LU1983299246.USD","LU2471134523.USD","LU0122379950.USD","IE00BWXC8680.SGD","LU2213496289.HKD","LU2756315318.SGD","LU1720051017.SGD","LU2237443895.HKD","LU2112291526.USD","SGXZ99366536.SGD","IE00BK4W5L77.USD","LU2271345857.HKD","NVOH","LU0203202063.USD","LU0225283273.USD","LU1323610961.USD","LU2746668974.SGD","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624213745","title":"減肥藥雙雄對決升級！禮來殺入「口服版」戰場","url":"https://stock-news.laohu8.com/highlight/detail?id=2624213745","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624213745?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 10:44","pubTimestamp":1775097884,"startTime":"0","endTime":"0","summary":"“口服时代”来了","market":"sh","thumbnail":"https://img3.gelonghui.com/79128-204a60c4-a36a-4bfc-a3d8-664344459bb0.jpg?guru_height=852&guru_width=1280&guru_size=359037","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/79128-204a60c4-a36a-4bfc-a3d8-664344459bb0.jpg?guru_height=852&guru_width=1280&guru_size=359037"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ce4b7877932b5a888416bb320979bf5f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4277339","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["SGXZ57979304.SGD","LU0122379950.USD","BK4532","LU1061106388.HKD","LU1974910355.USD","IE00BN29S564.USD","LU1057294990.SGD","LU0320765059.SGD","LU2023251221.USD","IE00BK4W5M84.HKD","LU2357305700.SGD","LU0096364046.USD","LU0672654240.SGD","LU2491049909.HKD","LU0203201768.USD","SG9999014880.SGD","BK4581","LU2264538146.SGD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","LU2237443382.USD","LU0058720904.USD","LU2746668461.USD","LU1629891620.HKD","LU1989771016.USD","LU0097036916.USD","LU0323591593.USD","LU0198837287.USD","SG9999015952.SGD","LU0106261372.USD","LU2265009873.SGD","LU1868837136.USD","LU1232071149.USD","IE00BKDWB100.SGD","LU2417539215.USD","SGXZ81514606.USD","SG9999015986.USD","LU2168564222.USD","LU0820561818.USD","LU2324357040.USD","LU0109391861.USD","LU0471298777.SGD","BK4534","LU1064131342.USD","ELIL","LU2471134879.HKD","IE00B1XK9C88.USD","LU2552382132.HKD","NVOH","LU2471134523.USD","LU2471134796.USD","IE00BJT1NW94.SGD","LU2471134952.CNY","LU2746668974.SGD","LU1804176565.USD","BK4007","IE00B775H168.HKD","LU0820562030.AUD","LU0114720955.EUR","LU1868836591.USD","LU2237443622.USD","LU2089284900.SGD","LU2361045086.USD","LU2756315318.SGD","LU2896262040.SGD","LU0094547139.USD","LU2237443549.SGD","SG9999014906.USD","GB00BDT5M118.USD","LU1720051108.HKD","IE0009355771.USD","IE00BJLML261.HKD","SG9999018857.SGD","IE00BWXC8680.SGD","IE0002141913.USD","LU2602419157.SGD","IE00BJJMRY28.SGD","LU0353189680.USD","LU0466842654.USD","LU2491050071.SGD","LU0158827781.USD","LU0353189763.USD","LU0266013472.USD","LU2089283258.USD","SGXZ51526630.SGD","LU1267930730.SGD","LU2063271972.USD","LU2552382058.USD","LU2168564065.EUR","SG9999013999.USD","LU0079474960.USD","LU0210536198.USD","LU0823434740.USD","LU2028103732.USD","LU2237438978.USD","LU1814569148.SGD","LU0006306889.USD","LU2756315664.SGD","SGXZ31699556.SGD","BK4516","LU0943347566.SGD","LU2112291526.USD","LU1093756325.SGD","SG9999014898.SGD","IE00B4R5TH58.HKD","IE00BFSS8Q28.SGD","LU2552382215.SGD","LU2168564149.EUR","LU1291159041.SGD","LU0238689110.USD","BK4588","LU0708995401.HKD","LU0889565916.HKD","LU1366192091.USD","LLII","LU1917777945.USD","LU1983299246.USD","LU2237443978.SGD","IE0005OL40V9.USD","LU0882574055.USD","IE00B4JS1V06.HKD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU1280957306.USD","LU2023250330.USD","LU2089984988.USD","IE00B2B36J28.USD","LU1069344957.HKD","LU2168564495.EUR","BK4533","LU2361044865.SGD","LU2360106947.USD","LU2111349929.HKD","LU2750360641.GBP","IE00B7KXQ091.USD","LU1551013342.USD","SG9999015945.SGD","LU1093756168.USD","LU0820561909.HKD","LU2462157665.USD","IE00BKVL7J92.USD","NVOX","SG9999017495.SGD","LU1623119135.USD","LU2468319806.SGD","LU2750360997.AUD","LU0354030438.USD","LU1868837300.USD","LU0256863902.USD","LU0787776722.HKD","LU1548497426.USD","LU1988902786.USD","LU0154236417.USD","LU0456855351.SGD","LU2456880835.USD","LU2491050154.USD","LU1323610961.USD","LU2168563687.JPY","LU1035775433.USD","LU0354030511.USD","LU0823416689.USD","LU0432979614.USD","LU0882574139.USD","IE0004445239.USD","IE00BJJMRX11.SGD","LU0061475181.USD","LU1551013425.SGD","LU1868836757.USD","SG9999001176.USD","LU0256863811.USD","LLYX","LLYZ","SG9999001176.SGD","LU2023250504.SGD","LLY","IE0004445015.USD","LU0158827948.USD","LU0786609619.USD","LU2213496289.HKD","LU0417517546.SGD","LU0385154629.USD","LU1712237335.SGD","LU0109394709.USD","ELIS","LU0320765992.SGD","LU0964807845.USD","LU2271345857.HKD","LU2361044949.HKD","BK4585","LU0689472784.USD","SG9999018865.SGD","SGXZ99366536.SGD","LU2211815571.USD","LU0640476718.USD","LU2236285917.USD","LU1127390331.HKD","LU1023059063.AUD","LU2461242641.AUD","LU2108987350.USD","LU0289739699.SGD","LU0316494557.USD","IE00BFSS7M15.SGD","SG9999014914.USD","LU1868836914.USD","LU0471298694.HKD","LU0203202063.USD","LU0683600562.USD","LU2087625088.SGD","BK4599","IE00BKPKM429.USD","IE00BZ1G4Q59.USD","LU2237443465.HKD","LU2106854487.HKD","LU2237443895.HKD","SG9999015978.USD","LU0225283273.USD","LU0234572021.USD","LU1720051017.SGD","LU0823434583.USD","IE0001KFT4U8.USD","IE00BK4W5L77.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624510807","title":"禮來口服減肥藥獲批 加劇與諾和諾德競爭","url":"https://stock-news.laohu8.com/highlight/detail?id=2624510807","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624510807?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 23:54","pubTimestamp":1775058899,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ce4b7877932b5a888416bb320979bf5f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0094547139.USD","LU2168564495.EUR","NVOX","LU1061106388.HKD","LU0943347566.SGD","IE00B7KXQ091.USD","LU0882574139.USD","LU2108987350.USD","IE00BK4W5L77.USD","LU2462157665.USD","NVO","LU0820561818.USD","LU2746668461.USD","LU0289739699.SGD","ELIS","IE00B4JS1V06.HKD","LU0786609619.USD","LU0006306889.USD","LU2237443382.USD","NVOH","LU0689472784.USD","IE00BJT1NW94.SGD","LU0210536198.USD","LU0823434583.USD","LU0096364046.USD","LU2028103732.USD","LU1057294990.SGD","LU1291159041.SGD","LU1712237335.SGD","IE0001KFT4U8.USD","LU0672654240.SGD","LU2471134796.USD","LU0823416689.USD","LU2552382215.SGD","LU1145028129.USD","LU1917777945.USD","IE00BZ1G4Q59.USD","LU0471298694.HKD","LU2106854487.HKD","SG9999014880.SGD","SG9999015986.USD","LU1868836914.USD","IE0004445239.USD","IE00BJJMRZ35.SGD","SG9999014914.USD","BK4533","LU1127390331.HKD","LU2602419157.SGD","LU1232071149.USD","IE0002141913.USD","IE0009355771.USD","LU2168564149.EUR","LU1804176565.USD","LU2236285917.USD","IE00BKPKM429.USD","LU1629891620.HKD","SG9999015978.USD","ELIL","LU2360106947.USD","SGXZ81514606.USD","LU2237443978.SGD","LU2168564065.EUR","LU0234572021.USD","LU0889565916.HKD","SGXZ51526630.SGD","LU0640476718.USD","LU2756315664.SGD","LU0385154629.USD","LU0323591593.USD","LU2211815571.USD","LU1720051017.SGD","LU2491049909.HKD","IE00B2B36J28.USD","LU1023059063.AUD","LU0354030438.USD","LLY","LU0114720955.EUR","LU2111349929.HKD","LU0471298777.SGD","LU0256863902.USD","LU1814569148.SGD","LU0354030511.USD","LU2750360997.AUD","SG9999018857.SGD","LU0820562030.AUD","LU2264538146.SGD","IE00B1XK9C88.USD","LU0316494557.USD","LU0203202063.USD","LU2324357040.USD","LU0079474960.USD","LU2089284900.SGD","LU2237438978.USD","BK4534","LU2456880835.USD","LU0964807845.USD","LU2746668974.SGD","LU2271345857.HKD","LU1093756325.SGD","LU0320765992.SGD","LU2491050071.SGD","LU2750360641.GBP","LU2491050154.USD","LU2089283258.USD","LU1323610961.USD","BK4581","BK4599","LU0198837287.USD","SGXZ57979304.SGD","IE00BFSS8Q28.SGD","LU0456855351.SGD","LU2552382132.HKD","LU2023250504.SGD","LU2471134879.HKD","LU2213496289.HKD","LU1551013342.USD","LU2237443549.SGD","BK4532","LU0683600562.USD","BK4588","LU1974910355.USD","IE00BFSS7M15.SGD","LU1868837300.USD","IE00BWXC8680.SGD","LLYZ","SG9999001176.SGD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU0353189763.USD","LU1868836757.USD","IE00B1BXHZ80.USD","LU1720051108.HKD","LU0158827781.USD","LU0238689110.USD","LU2063271972.USD","LU2361045086.USD","LU2357305700.SGD","LU1069344957.HKD","LU1035775433.USD","LU2461242641.AUD","LU0708995401.HKD","BK4007","LU2417539215.USD","LU2468319806.SGD","LU2023250330.USD","LLII","LU0820561909.HKD","LU0106261372.USD","SGXZ31699556.SGD","LU1868836591.USD","LU0154236417.USD","LU0203201768.USD","SG9999014898.SGD","LU1548497426.USD","LU0225283273.USD","LU2361044865.SGD","LU2112291526.USD","LU2896262040.SGD","IE00BKVL7J92.USD","LU0061475181.USD","LU2237443622.USD","LU0158827948.USD","IE00B4R5TH58.HKD","LU2471134523.USD","SG9999017495.SGD","LU1989771016.USD","LU0122379950.USD","LU0787776722.HKD","LU1868837136.USD","LU2552382058.USD","LU0266013472.USD","LU1280957306.USD","LU2023251221.USD","LU2089984988.USD","IE00BJLML261.HKD","LU0109394709.USD","LU1623119135.USD","LU2087625088.SGD","LU0823434740.USD","BK4516","LU2756315318.SGD","LU0417517546.SGD","LU0256863811.USD","LU2471134952.CNY","LU1988902786.USD","LU0097036916.USD","IE0004445015.USD","LU1551013425.SGD","LU2237443895.HKD","SG9999015945.SGD","BK4585","LU0432979614.USD","GB00BDT5M118.USD","IE00BN29S564.USD","LU0320765059.SGD","IE0005OL40V9.USD","LU2168564222.USD","LU1267930730.SGD","SG9999001176.USD","SGXZ99366536.SGD","LU1366192091.USD","IE00BKDWB100.SGD","LU0882574055.USD","IE00BK4W5M84.HKD","IE00B775H168.HKD","IE00BJJMRY28.SGD","LU1064131342.USD","LU2168563687.JPY","LLYX","LU1093756168.USD","LU2237443465.HKD","LU1983299246.USD","LU2361044949.HKD","SG9999018865.SGD","LU2265009873.SGD","SG9999015952.SGD","IE00BJJMRX11.SGD","LU0353189680.USD","LU0058720904.USD","LU0109391861.USD","SG9999014906.USD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622538856","title":"諾和諾德每周一次基礎胰島素製劑Awiqli獲美國FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2622538856","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622538856?lang=zh_tw&edition=fundamental","pubTime":"2026-03-28 14:06","pubTimestamp":1774678001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1093756325.SGD","NVOX","BK4588","BK4532","NVO","LU1093756168.USD","NVOH","BK4007","BK4599","IE00BZ1G4Q59.USD","LU0154236417.USD","IE00BKVL7J92.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622282640","title":"諾和諾德「周製劑」胰島素獲美國FDA批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2622282640","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622282640?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 19:52","pubTimestamp":1774612372,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德宣布，美国食品药品监督管理局(FDA)正式批准其Awiqli(依柯胰岛素注射液:700单位/毫升)上市。该药物主要作为饮食和运动的辅助手段，旨在帮助改善成人2型糖尿病患者的血糖控制。该注射液获批上升后将把每周多达七次的常规基础胰岛素注射大幅缩减至仅需一次，为患者提供了一种革命性的替代方案。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"298464","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0154236417.USD","IE00BKVL7J92.USD","LU1093756168.USD","NVOH","NVOX","IE00BZ1G4Q59.USD","NVO","LU1093756325.SGD","BK4532","BK4007","BK4588","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622846972","title":"美股異動丨諾和諾德盤前升逾2%，「周製劑」胰島素在美獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2622846972","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622846972?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 16:09","pubTimestamp":1774598948,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVOX","NVO","BK4588","BK4007","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD","NVOH","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","BK4599","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622148138","title":"糖果巨頭CEO加盟減重藥巨頭諾和諾德","url":"https://stock-news.laohu8.com/highlight/detail?id=2622148138","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622148138?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 12:01","pubTimestamp":1774584060,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK4007","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4532","NVO","LU1093756168.USD","NVOX","NVOH","LU0154236417.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622610848","title":"諾和諾德任命瑪氏公司CEO為董事會觀察員","url":"https://stock-news.laohu8.com/highlight/detail?id=2622610848","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622610848?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 23:20","pubTimestamp":1774538405,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4599","NVOH","LU1093756325.SGD","LU1093756168.USD","NVO","NVOX","IE00BKVL7J92.USD","BK4588","BK4007","BK4532","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622043829","title":"減重巨頭決戰線上，「可及性」成關鍵賽點","url":"https://stock-news.laohu8.com/highlight/detail?id=2622043829","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622043829?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 10:12","pubTimestamp":1774404748,"startTime":"0","endTime":"0","summary":"火爆全球多年的GLP-1减重药赛道，在2025年迎来了历史性转折点。01巨头攻守战，“可及性”成赛点对于如今的诺和诺德而言，药品可及性已然成为其在GLP-1赛道上仅存的竞争优势。显而易见，CagriSema未能在头对头试验中击败替尔泊肽，这场关键战役的失利，直接导致诺和诺德股价在次日暴跌14.64%。一旦Orforglipron顺利上市，诺和诺德独占的口服GLP-1市场将被打破，其仅存的可及性优势也将岌岌可危，甚至可能彻底失守。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774314534087933025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU1093756168.USD","BK4007","IE00BKVL7J92.USD","NVOH","LLY","IE00BZ1G4Q59.USD","NVO","LU0154236417.USD","BK4588","LU1093756325.SGD","BK4532","BK4599","NVOX","BK4585"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621037044","title":"「減肥神藥」，價格要崩了","url":"https://stock-news.laohu8.com/highlight/detail?id=2621037044","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621037044?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 11:52","pubTimestamp":1774324357,"startTime":"0","endTime":"0","summary":"文｜首席品牌评论2026年3月20日，一个值得写入中国医药产业史的日子。这一天，司美格鲁肽——这款被冠以“减肥神药”之名的全球药王，在中国的核心化合物专利正式到期。专利悬崖如期而至。悬崖之下，是一群早已架好梯子的药企。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774276430002024993","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["NVO","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4532","BK4007","LU1093756325.SGD","NVOX","BK4599","LU0154236417.USD","BK4588","LU1093756168.USD","NVOH","BK4585"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2621067907","title":"減重版司美格魯肽「上新」，更高劑量Wegovy已在美國獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2621067907","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621067907?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 20:57","pubTimestamp":1774270620,"startTime":"0","endTime":"0","summary":"诺和诺德近日宣布，美国食品药品监督管理局（FDA）已批准Wegovy?HD（每周一次司美格鲁肽注射液7.2mg），用于降低过多体重并长期维持减重效果。FDA此前已向Wegovy?HD授予“局长国家优先审批券”（CNPV），从而加快了其审批进程，并凸显其在应对关键患者需求及美国国家健康优先事项方面的潜力。该加速批准基于STEPUP试验项目研究结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603233681185257.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603233681185257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2361044865.SGD","BK4007","LU2361045086.USD","IE00B1XK9C88.USD","LU1989772923.USD","LU1093756325.SGD","LU1093756168.USD","IE00BWXC8680.SGD","IE00BKVL7J92.USD","LU0320765646.SGD","LU0868494617.USD","LU0942090050.USD","LU1236620834.HKD","LU2361044949.HKD","LU2756315664.SGD","IE00BSNM7G36.USD","LU1069344957.HKD","LU1989772840.SGD","LU0354030511.USD","LU1496350171.SGD","BK4533","BK4581","HD","BK4566","LU1551013425.SGD","LU0098860793.USD","LU0820561909.HKD","LU2461242641.AUD","LU0079474960.USD","SG9999001440.SGD","LU1496350502.SGD","LU0238689110.USD","NVOH","LU0820562030.AUD","NVOX","LU0823411888.USD","NVO","BK4504","LU1778281490.HKD","LU0943347566.SGD","BK4534","LU1674673691.USD","LU1551013342.USD","LU2756315318.SGD","LU1914381329.SGD","LU1162221912.USD","LU1929549753.HKD","LU0868494708.USD","LU1674673428.USD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621953726","title":"凌激副部長兼國際貿易談判副代表會見丹麥諾和諾德公司執行副總裁林意明","url":"https://stock-news.laohu8.com/highlight/detail?id=2621953726","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621953726?lang=zh_tw&edition=fundamental","pubTime":"2026-03-23 11:20","pubTimestamp":1774236000,"startTime":"0","endTime":"0","summary":"南方财经3月23日电，据商务部消息，3月20日，商务部副部长兼国际贸易谈判副代表凌激会见丹麦诺和诺德公司执行副总裁林意明，双方围绕企业在华经营情况、中国开放发展机遇等议题进行交流。凌激表示，近年来，中国科技创新能力快速提升，医药健康产业规模不断扩大。中国以新质生产力推动经济高质量发展，已成为全球创新策源地。希望诺和诺德持续深耕中国市场，为建设健康中国作出贡献。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603233680260164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BZ1G4Q59.USD","NVOX","NVOH","BK4007","NVO","IE00BKVL7J92.USD","BK4599","BK4532","BK4585","BK4588","LU1093756168.USD","LU1093756325.SGD","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620903249","title":"諾和諾德(NVO.US)擬在日本拓展減肥藥市場，「曲線入市「瞄準自費患者藍海","url":"https://stock-news.laohu8.com/highlight/detail?id=2620903249","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620903249?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 18:25","pubTimestamp":1773915956,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺和诺德公司正寻求通过瞄准愿意自费使用Wegovy等胰高血糖素样肽-1药物的患者，来扩大肥胖症治疗在日本的可及性。诺和诺德推动自费医疗的举措，反映了整个行业在渗透率不足的市场扩大治疗的更广泛努力。在肥胖症和罕见病疗法的推动下，诺和诺德日本业务部门去年收入增长了5.4%。\"诺和诺德在日本的努力可能沿袭了其在美国建立的直接面向消费者的销售路径。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVO","BK4532","IE00BKVL7J92.USD","LU1093756325.SGD","BK4588","BK4599","LU0154236417.USD","BK4585","LU1093756168.USD","NVOX","BK4007","IE00BZ1G4Q59.USD","NVOH"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620431362","title":"諾和諾德據悉正尋求拓寬日本患者獲取減肥藥的渠道","url":"https://stock-news.laohu8.com/highlight/detail?id=2620431362","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620431362?lang=zh_tw&edition=fundamental","pubTime":"2026-03-19 17:07","pubTimestamp":1773911228,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK4007","LU0154236417.USD","NVO","NVOX","BK4585","BK4532","LU1093756325.SGD","LU1093756168.USD","BK4599","IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620501842","title":"諾和諾德(NVO)股票3月18日盤中下跌3.12%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2620501842","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620501842?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 23:16","pubTimestamp":1773846978,"startTime":"0","endTime":"0","summary":"• FDA警告信指出司美格鲁肽产品存在违规行为。\n• 竞争加剧以及对研发管线的担忧影响了公司前景。\n• 修订后的2026年营收指引预示销售额将出现下滑。","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/Market-Movers/261695175-market-movers-nvo-20260318","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK7104","NVO","IE00BKVL7J92.USD","NVOH","BK4585","BK4599","NVOX","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756325.SGD","BK4532","BK4588","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620476890","title":"Structure肥胖藥物研究結果直追諾和諾德與禮來","url":"https://stock-news.laohu8.com/highlight/detail?id=2620476890","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620476890?lang=zh_tw&edition=fundamental","pubTime":"2026-03-17 23:08","pubTimestamp":1773760090,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2361045086.USD","LU2089984988.USD","LU1868837300.USD","LU2896262040.SGD","LU0823416689.USD","LU2264538146.SGD","LU2211815571.USD","LU1069344957.HKD","LU1366192091.USD","BK4516","LU0708995401.HKD","LU0256863811.USD","LU1291159041.SGD","LU1989771016.USD","LU0256863902.USD","LU1548497426.USD","LU0943347566.SGD","SG9999001176.USD","BK4532","LU0079474960.USD","LU1551013342.USD","LU1267930730.SGD","LU1323610961.USD","LU2236285917.USD","LU0353189763.USD","IE00BN29S564.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU0689472784.USD","SG9999015986.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00BJJMRX11.SGD","LU2471134796.USD","GB00BDT5M118.USD","SG9999018865.SGD","LU0154236417.USD","LU0882574139.USD","SG9999015952.SGD","LU2602419157.SGD","BK4585","LU1868836757.USD","LU2237443549.SGD","IE00BFSS8Q28.SGD","IE0001KFT4U8.USD","LU2237443382.USD","LU1127390331.HKD","LU2471134952.CNY","LU2023250504.SGD","LU0061475181.USD","IE00BJLML261.HKD","LU0094547139.USD","LU2461242641.AUD","LU1917777945.USD","LU0006306889.USD","LU0058720904.USD","LU2237443978.SGD","LU0432979614.USD","IE00B1BXHZ80.USD","LU1093756168.USD","ELIS","LU0203202063.USD","LU0456855351.SGD","LU0158827948.USD","LU2357305700.SGD","LU1988902786.USD","LU0109391861.USD","SG9999014880.SGD","LU2552382215.SGD","LU0234572021.USD","LU2168563687.JPY","LU0122379950.USD","IE00BZ1G4Q59.USD","LU0096364046.USD","LU1712237335.SGD","LU2417539215.USD","IE00B1XK9C88.USD","LU2756315664.SGD","LU2491049909.HKD","IE00BWXC8680.SGD","LU0198837287.USD","LLYX","LU0385154629.USD","LU2361044865.SGD","LU2471134879.HKD","BK4599","IE00B4JS1V06.HKD","IE00BJJMRZ35.SGD","LU1804176565.USD","LU2168564149.EUR","LU0882574055.USD","LU0683600562.USD","LU2462157665.USD","SGXZ99366536.SGD","LU0106261372.USD","LU0210536198.USD","IE00BJT1NW94.SGD","LU1551013425.SGD","LU2746668461.USD","SGXZ81514606.USD","LU2168564222.USD","LU2756315318.SGD","LU0466842654.USD","IE0004445239.USD","LU2089284900.SGD","LU0354030511.USD","LLII","LU0640476718.USD","LU2168564495.EUR","LU2087625088.SGD","LU2237443895.HKD","LLYZ","SG9999014914.USD","BK4581","LU1280957306.USD","LU0471298694.HKD","IE00BK4W5M84.HKD","LU0323591593.USD","LU1061106388.HKD","LU2750360997.AUD","LU0417517546.SGD","LU1064131342.USD","LU2750360641.GBP","BK4588","LU2237443622.USD","LU2237443465.HKD","LU0889565916.HKD","ELIL","NVOH","SG9999015978.USD","SG9999018857.SGD","LU2456880835.USD","LU2213496289.HKD","LU2265009873.SGD","LU2023250330.USD","IE00BKPKM429.USD","LU0114720955.EUR","LU2491050071.SGD","LU1093756325.SGD","LU1868837136.USD","LU0320765059.SGD","LU0820562030.AUD","BK4007","LU0097036916.USD","LU2089283258.USD","LU2491050154.USD","LU0471298777.SGD","LU1023059063.AUD","IE00BKDWB100.SGD","LU1868836591.USD","LU2237438978.USD","LU1623119135.USD","IE00BKVL7J92.USD","LU0354030438.USD","SGXZ57979304.SGD","LU1629891620.HKD","LU1814569148.SGD","LU2168564065.EUR","LU2468319806.SGD","BK4534","LU0320765992.SGD","IE0002141913.USD","LU2552382132.HKD","IE00BFSS7M15.SGD","LU0238689110.USD","SG9999014906.USD","LU0820561818.USD","LU1974910355.USD","IE00BK4W5L77.USD","BK4533","IE00B7KXQ091.USD","LU1035775433.USD","LU2471134523.USD","LU2108987350.USD","LU0787776722.HKD","IE00BJJMRY28.SGD","LU2360106947.USD","SG9999017495.SGD","IE00B775H168.HKD","GPCR","LU0266013472.USD","LU0820561909.HKD","LU2106854487.HKD","LU0109394709.USD","SGXZ51526630.SGD","LU2063271972.USD","SG9999014898.SGD","LU0225283273.USD","SG9999013999.USD","LU2361044949.HKD","IE0005OL40V9.USD","LU0823434583.USD","LU2112291526.USD","LU1720051017.SGD","LU0158827781.USD","LU0786609619.USD","LU2271345857.HKD","LU1983299246.USD","LU2746668974.SGD","LU2023251221.USD","LU1057294990.SGD","SG9999001176.SGD","LU2324357040.USD","SGXZ31699556.SGD","LU0353189680.USD","LU0823434740.USD","IE00B4R5TH58.HKD","LU0316494557.USD","IE0004445015.USD","NVOX","LU2552382058.USD","LU0964807845.USD","LU2028103732.USD","SG9999015945.SGD","LU1868836914.USD","LU1720051108.HKD","LU1232071149.USD","LU0203201768.USD","LU2111349929.HKD","LU1145028129.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619019014","title":"反彈50%只是開始？深度覆盤HIMS與藥王的「世紀大和解」","url":"https://stock-news.laohu8.com/highlight/detail?id=2619019014","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619019014?lang=zh_tw&edition=fundamental","pubTime":"2026-03-13 21:20","pubTimestamp":1773408035,"startTime":"0","endTime":"0","summary":"在狂热中保持一份清醒","market":"us","thumbnail":"https://img3.gelonghui.com/3c716-ca1a8464-8f16-4866-ab41-c44262ef4bdf.jpg?guru_height=876&guru_width=1605&guru_size=79794","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/3c716-ca1a8464-8f16-4866-ab41-c44262ef4bdf.jpg?guru_height=876&guru_width=1605&guru_size=79794"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4071127","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["IE00BZ1G4Q59.USD","BK4196","NVOX","LU1093756168.USD","NVOH","HIMY","BK4007","HMYY","LU1093756325.SGD","IE00BKVL7J92.USD","BK4599","BK4532","BK4585","BK4588","HIMS","HIYY","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}